FAB — Fusion Antibodies Share News
0.000.00%
- £13.64m
- £13.30m
- £1.97m
REG - AIM - AIM Notice - 22/10/2024
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Issue of shares to non-executive directors
AnnouncementREG - Fusion Antibodies - Result of AGM
AnnouncementREG - Fusion Antibodies - AGM statement and trading update
AnnouncementREG - Fusion Antibodies - Block admission six monthly return
AnnouncementREG - Fusion Antibodies - Notice of AGM
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementRCS - Fusion Antibodies - Investor presentation
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Final Results
AnnouncementRCS - Fusion Antibodies - Expansion to OptiMAL collaboration agreement
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementRCS - Fusion Antibodies - Launch of New Interactive Investor Hub
AnnouncementREG - Fusion Antibodies - Trading update
AnnouncementREG - Fusion Antibodies - New contract with existing client
AnnouncementRCS - Fusion Antibodies - Investor presentation
AnnouncementREG - Fusion Antibodies - Year-end trading statement
AnnouncementREG - Fusion Antibodies - Change of auditor
Announcement